Adage Capital Partners Gp, L.L.C. Nektar Therapeutics Transaction History

Adage Capital Partners Gp, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$46.25 - $104.45 $56.4 Million - $127 Million	-1,219,087 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$57.4 - $108.44 $62 Million - $117 Million	1,080,087 Added 777.04%	1,219,087 $130 Million
Q4 2017 Feb 14, 2018	BUY	$23.02 - $60.5 $3.2 Million - $8.41 Million	139,000	139,000 $8.3 Million

15.6M

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $10.6B
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.